Catalyst Wire Dossier Catalyst Wire Dossier

Human Neuregulin-1

neuregulin-1 · Zensun Sci. & Tech. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Neuregulin-1, covering 2025-02-10 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure [Phase 2]

See pricing